WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Stock Ownership - Who owns Adma Biologics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adma Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam S. GrossmanPresident and CEO2025-12-156,000$19.79
$118.74kSell
Adam S. GrossmanPresident and CEO2025-12-1515,000$5.40
$81.00kBuy
Adam S. GrossmanPresident and CEO2025-12-1515,000$19.79
$296.85kSell
Adam S. GrossmanPresident and CEO2025-11-1915,000$5.40
$81.00kBuy
Adam S. GrossmanPresident and CEO2025-11-1915,000$16.00
$240.00kSell
Adam S. GrossmanPresident and CEO2025-11-196,000$16.00
$96.00kSell
Adam S. GrossmanPresident and CEO2025-10-2415,000$5.40
$81.00kBuy
Adam S. GrossmanPresident and CEO2025-10-246,000$16.00
$96.00kSell
Adam S. GrossmanPresident and CEO2025-10-2415,000$16.00
$240.00kSell
Adam S. GrossmanPresident and CEO2025-09-1515,000$16.13
$241.95kSell

1 of 7

ADMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADMA insiders and whales buy or sell their stock.

ADMA Shareholders

What type of owners hold Adma Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.27%36,333,325$584.60MInstitution
Vanguard Group Inc8.76%20,854,669$335.55MInstitution
State Street Corp5.71%13,597,259$218.78MInstitution
Perceptive Advisors LLC5.57%13,262,375$213.39MInsider
Divestiture Trust Biotest5.41%12,886,740$207.35MInsider
Sachem Head Capital Management LP4.78%11,375,000$183.02MInstitution
Ag Biotest4.25%10,109,534$162.66MInsider
Westfield Capital Management Co LP2.94%6,992,907$112.52MInstitution
Capital Research Global Investors2.79%6,637,472$106.80MInstitution
Aisling Capital II LP2.58%6,136,998$98.74MInsider

1 of 3

ADMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMA72.19%23.69%Net SellingNet Selling
ACAD50.83%38.18%Net SellingNet Selling
LGND14.55%85.45%Net SellingNet Selling
NAMS47.01%35.93%Net SellingNet Selling
TERN64.88%23.00%Net SellingNet Selling
View Top Biotech Stocks

Adma Biologics Stock Ownership FAQ

Who owns Adma Biologics?

Adma Biologics (NASDAQ: ADMA) is owned by 72.19% institutional shareholders, 23.69% Adma Biologics insiders, and 4.12% retail investors. Perceptive Advisors LLC is the largest individual Adma Biologics shareholder, owning 13.26M shares representing 5.57% of the company. Perceptive Advisors LLC's Adma Biologics shares are currently valued at $211.53M.

If you're new to stock investing, here's how to buy Adma Biologics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.